Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 4/20 | 0.58 |
| ▸ | PPARA | Q07869 | 6/20 | 0.58 |
| ▸ | PPARG | P37231 | 4/20 | 0.58 |
| ▸ | PPARD | Q03181 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3963125 | 1.00 | ACE (0.58) | ACEPPARAPPARGPPARD | |
| Hydrochloric Acid SCHEMBL18260619 | 0.98 | ACE (0.57) | ACEPPARAPPARGPPARD | |
| SCHEMBL2240346 | 0.89 | ACE (0.57) | ACEPPARAPPARGPPARD | |
| SCHEMBL14405000 | 0.87 | ACE (0.59) | ACEPPARAPPARGPPARD | |
| SCHEMBL5217215 | 0.83 | ACE (0.62) | ACEPPARAPPARGPPARD | |
| SCHEMBL8997921 | 0.83 | ACE (0.62) | ACEPPARAPPARGPPARD | |
| SCHEMBL5610149 | 0.83 | ACE (0.58) | ACEPPARAPPARGPPARD | |
| SCHEMBL8997911 | 0.83 | ACE (0.62) | ACEPPARAPPARGPPARD | |
| SCHEMBL11347298 | 0.81 | PPARA (0.61) | ACEPPARAPPARG | |
| SCHEMBL14383383 | 0.81 | ACE (0.59) | ACEPPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10925977-B2 | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications | Ceil>Point, LLC (US) | 2021-02-23 | — | — | US | disclosed |
| US-10814013-B2 | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-10-27 | — | — | US | disclosed |
| EP-2079486-B1 | EFFICIENT SYNTHESIS OF CHELATORS FOR NUCLEAR IMAGING AND RADIOTHERAPY: COMPOSITIONS AND APPLICATIONS | UNIV TEXAS (US) | 2018-04-04 | — | — | EP | disclosed |
| EP-3102588-A1 | A KIT FOR PREPARING A RADIOPHARMACEUTICAL | The South African Nuclear Energy Corporation Limited (ZA) | 2016-12-14 | — | — | EP | disclosed |
| US-20160346412-A1 | A KIT FOR PREPARING A RADIOPHARMACEUTICAL | THE SOUTH AFRICAN NUCLEAR ENERGY CORPORATION LIMITED (ZA) | 2016-12-01 | — | — | US | disclosed |
| WO-2015118498-A1 | A KIT FOR PREPARING A RADIOPHARMACEUTICAL | THE SOUTH AFRICAN NUCLEAR ENERGY CORPORATION LIMITED (ZA) | 2015-08-13 | — | — | WO | disclosed |
| US-20130039853-A1 | EFFICIENT SYNTHESIS OF CHELATORS FOR NUCLEAR IMAGING AND RADIOTHERAPY: COMPOSITIONS AND APPLICATIONS | CELL>POINT, LLC | 2013-02-14 | — | — | US | disclosed |
| EP-2079486-A2 | EFFICIENT SYNTHESIS OF CHELATORS FOR NUCLEAR IMAGING AND RADIOTHERAPY: COMPOSITIONS AND APPLICATIONS | The Board of Regents of The University of Texas System (US) | 2009-07-22 | — | — | EP | disclosed |
| US-20080107598-A1 | Efficient Synthesis of Chelators for Nuclear Imaging and Radiotherapy: Compositions and Applications | COLIP, GREGORY RUSSELL | 2008-05-08 | — | — | US | disclosed |
| WO-2008045604-A2 | EFFICIENT SYNTHESIS OF CHELATORS FOR NUCLEAR IMAGING AND RADIOTHERAPY: COMPOSITIONS AND APPLICATIONS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2008-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080107598-A1 | Efficient Synthesis of Chelators for Nuclear Imaging and Radiotherapy: Compositions and Applications | TNNI3, CAD, TNNT2 | ACE 4011/4885PPARA 1561/4885PPARG 1150/4885 |
| US-10814013-B2 | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications | TNNI3, CAD, TNNT2 | ACE 4011/4885PPARA 1561/4885PPARG 1150/4885 |
| US-10925977-B2 | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications | TNNI3, CAD, TNNT2 | ACE 4011/4885PPARA 1561/4885PPARG 1150/4885 |
| US-20130039853-A1 | EFFICIENT SYNTHESIS OF CHELATORS FOR NUCLEAR IMAGING AND RADIOTHERAPY: COMPOSITIONS AND APPLICATIONS | TNNI3, CAD, TNNT2 | ACE 4011/4885PPARA 1561/4885PPARG 1150/4885 |
| US-20160346412-A1 | A KIT FOR PREPARING A RADIOPHARMACEUTICAL | KIT, PROKR1, ACKR3 | ACE 3028/4885PPARA 4024/4885PPARG 3541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.